The Italian Pharmaceutical Market
The Italian pharmaceuticals market generated total revenues of $23.6 billion in 2006, this representing a compound annual growth rate (CAGR) of 2.4% for the five-year period spanning 2002-2006.
|
Belgian Pharmaceutical Market: Overview
The Belgian pharmaceuticals market generated total revenues of $5 billion in 2006
|
The Norwegian Pharmaceuticals Market: Overview
The performance of the market is forecast to accelerate
|
Pharmaceutical Market in Czech Republic: Overview
In 2011, the Czech pharmaceuticals market is forecast to have a value of $2.8 billion
|
The Swedish Pharmaceutical Market: Overview
The Swedish market is forecast to accelerate its current performance, with an anticipated CAGR of 5.9% for the period 2005-2010 expected to drive the market to a value of $4.7 billion.
|
Cancer Market: Overview
Strong sales growth drives the market
|
Overview of Parallel Trade
Parallel trade continues to pose a serious threat to pharmaceutical companies
|
Neurological Disorders and High Level of Unmet Clinical Need to Create Opportunities in European Central Nervous System Therapeutics Market
European Central Nervous System (CNS) Therapeutics Markets earned revenues of $22.90 billion in 2005 and estimates this to reach $31.31 billion in 2012.
|
The outsourcing in formulation development
Leading to greater strategic business opportunities for contract resource organizations and pharmaceutical companies
|
U.S. prescription drug sales grew 5.4 percent to $251.8 billion in 2005
New Product Launches, Medicare Part D Help Fuel Projected U.S. Pharma Market Growth of 5-to-8 Percent Over Next Five Years
|
|
|
